Since estrogen promotes growth of breast cancer and 70% of breast cancer patients are estrogen receptor (ER)-positive, antiestrogens (e.g. tamoxifen) are frequently used to treat patients with breast cancer. This evidence concerns the gene ESR1 and breast cancer.